192 related articles for article (PubMed ID: 12057135)
1. Primary soft tissue sarcoma of the breast.
Trent II JC; Benjamin RS; Valero V
Curr Treat Options Oncol; 2001 Apr; 2(2):169-76. PubMed ID: 12057135
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and management of primary breast sarcoma.
Al-Benna S; Poggemann K; Steinau HU; Steinstraesser L
Breast Cancer Res Treat; 2010 Aug; 122(3):619-26. PubMed ID: 20480227
[TBL] [Abstract][Full Text] [Related]
3. Treatment of soft tissue sarcoma in childhood and adolescence. A report of the German Cooperative Soft Tissue Sarcoma Study.
Koscielniak E; Jürgens H; Winkler K; Bürger D; Herbst M; Keim M; Bernhard G; Treuner J
Cancer; 1992 Nov; 70(10):2557-67. PubMed ID: 1482503
[TBL] [Abstract][Full Text] [Related]
4. Role of radiotherapy in sarcoma of the breast--a retrospective review of the M.D. Anderson experience.
Barrow BJ; Janjan NA; Gutman H; Benjamin RS; Allen P; Romsdahl MM; Ross MI; Pollock RE
Radiother Oncol; 1999 Aug; 52(2):173-8. PubMed ID: 10577703
[TBL] [Abstract][Full Text] [Related]
5. Conservative surgery after neoadjuvant chemotherapy in patients with operable breast cancer.
Franceschini G; Di Leone A; Natale M; Sanchez MA; Masett R
Ann Ital Chir; 2018; 89():290. PubMed ID: 30352955
[TBL] [Abstract][Full Text] [Related]
6. Paediatric non-rhabdomyosarcoma soft tissue sarcomas: the prospective NRSTS 2005 study by the European Pediatric Soft Tissue Sarcoma Study Group (EpSSG).
Ferrari A; van Noesel MM; Brennan B; Zanetti I; Corradini N; Casanova M; Berlanga P; Merks JHM; Alaggio R; Schifflers S; Ramirez-Villar GL; Giraudo C; Burrieza GG; Safwat A; Bisogno G; De Salvo GL; Orbach D
Lancet Child Adolesc Health; 2021 Aug; 5(8):546-558. PubMed ID: 34214481
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy, irradiation, and surgery for function-preserving therapy of primary extremity soft tissue sarcomas: initial treatment with ifosfamide, mitomycin, doxorubicin, and cisplatin plus granulocyte macrophage-colony-stimulating factor.
Edmonson JH; Petersen IA; Shives TC; Mahoney MR; Rock MG; Haddock MG; Sim FH; Maples WJ; O'Connor MI; Gunderson LL; Foo ML; Pritchard DJ; Buckner JC; Stafford SL
Cancer; 2002 Feb; 94(3):786-92. PubMed ID: 11857314
[TBL] [Abstract][Full Text] [Related]
8. Phyllodes tumors of the breast.
Khan SA; Badve S
Curr Treat Options Oncol; 2001 Apr; 2(2):139-47. PubMed ID: 12057132
[TBL] [Abstract][Full Text] [Related]
9. An analysis of 78 breast sarcoma patients without distant metastases at presentation.
McGowan TS; Cummings BJ; O'Sullivan B; Catton CN; Miller N; Panzarella T
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):383-90. PubMed ID: 10661345
[TBL] [Abstract][Full Text] [Related]
10. Should patients with high-risk soft tissue sarcoma receive adjuvant chemotherapy?
Schuetze SM; Patel S
Oncologist; 2009 Oct; 14(10):1003-12. PubMed ID: 19808770
[TBL] [Abstract][Full Text] [Related]
11. Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical Trial.
Issels RD; Lindner LH; Verweij J; Wessalowski R; Reichardt P; Wust P; Ghadjar P; Hohenberger P; Angele M; Salat C; Vujaskovic Z; Daugaard S; Mella O; Mansmann U; Dürr HR; Knösel T; Abdel-Rahman S; Schmidt M; Hiddemann W; Jauch KW; Belka C; Gronchi A;
JAMA Oncol; 2018 Apr; 4(4):483-492. PubMed ID: 29450452
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant therapy for extremity sarcomas.
Schlieman M; Smith R; Kraybill WG
Curr Treat Options Oncol; 2006 Nov; 7(6):456-63. PubMed ID: 17032558
[TBL] [Abstract][Full Text] [Related]
13. Treatment and outcomes of patients with primary breast sarcoma.
Fields RC; Aft RL; Gillanders WE; Eberlein TJ; Margenthaler JA
Am J Surg; 2008 Oct; 196(4):559-61. PubMed ID: 18723152
[TBL] [Abstract][Full Text] [Related]
14. Combination of Cisplatin, Ifosfamide, and Adriamycin as Neoadjuvant Chemotherapy for Extremity Soft Tissue Sarcoma: A Report of Twenty-Eight Patients.
Wang B; Yu X; Xu S; Xu M
Medicine (Baltimore); 2016 Jan; 95(4):e2611. PubMed ID: 26825914
[TBL] [Abstract][Full Text] [Related]
15. Limb salvage by neoadjuvant isolated perfusion with TNFalpha and melphalan for non-resectable soft tissue sarcoma of the extremities.
Lejeune FJ; Pujol N; Liénard D; Mosimann F; Raffoul W; Genton A; Guillou L; Landry M; Chassot PG; Chiolero R; Bischof-Delaloye A; Leyvraz S; Mirimanoff RO; Bejkos D; Leyvraz PF
Eur J Surg Oncol; 2000 Nov; 26(7):669-78. PubMed ID: 11078614
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant interstitial high-dose-rate (HDR) brachytherapy combined with systemic chemotherapy in patients with breast cancer.
Roddiger SJ; Kolotas C; Filipowicz I; Kurek R; Kuner RP; Martin T; Baltas D; Rogge B; Kontova M; Hoffmann G; Pollow B; Zamboglou N
Strahlenther Onkol; 2006 Jan; 182(1):22-9. PubMed ID: 16404517
[TBL] [Abstract][Full Text] [Related]
17. Current strategy for triple-negative breast cancer: appropriate combination of surgery, radiation, and chemotherapy.
Yagata H; Kajiura Y; Yamauchi H
Breast Cancer; 2011 Jul; 18(3):165-73. PubMed ID: 21290263
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy influences the pseudocapsule composition in soft tissue sarcomas.
O'Donnell PW; Manivel JC; Cheng EY; Clohisy DR
Clin Orthop Relat Res; 2014 Mar; 472(3):849-55. PubMed ID: 23640206
[TBL] [Abstract][Full Text] [Related]
19. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma.
Pervaiz N; Colterjohn N; Farrokhyar F; Tozer R; Figueredo A; Ghert M
Cancer; 2008 Aug; 113(3):573-81. PubMed ID: 18521899
[TBL] [Abstract][Full Text] [Related]
20. Advances in chemotherapy for patients with extremity soft tissue sarcoma.
Eilber FC; Tap WD; Nelson SD; Eckardt JJ; Eilber FR
Orthop Clin North Am; 2006 Jan; 37(1):15-22. PubMed ID: 16311108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]